Key facts
- Notable investors include Andera Partners, Capza, Barings BDC.
- Status: Privately Held (backing).
Investors
3- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Biolam Groupe
- ·The full record, as it builds
Funding rounds
No funding rounds for Biolam Groupe are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Biolam Groupe
Operator of medical biology laboratories intended to serve patients and healthcare providers. The company conducts diagnostic testing, sample analysis, and biological monitoring through a network of accredited labs, thereby supporting clinical decision-making and public health management.
- Sector
- Healthcare
- HQ
- Beauvais, France
- Founded
- 2000
- Employees
- 150
- Website
- groupebiolam.com/
- Ownership
- Privately Held (backing)
Biolam Groupe doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Biolam Groupe shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Biolam Groupe in its N-PORT filings yet. We sweep new filings monthly.